Plain-English translation of NCT02630121 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether —a nasal decongestant spray—when combined with fluticasone propionate (a steroid nasal spray you may already be using), can help reduce sleep apnea severity and improve nasal congestion. Researchers will measure how this medication affects your breathing during sleep and how congested your nose feels.
Many people with nasal congestion and mild sleep apnea don't improve enough with steroid sprays alone. This study explores whether adding a decongestant to the treatment can help both conditions at the same time.
You likely qualify if…
You likely don't qualify if…
You will spray medication into your nose twice daily for several weeks, alternating between the combination treatment and a placebo (dummy spray) in a crossover design—meaning you'll try both at different times. You'll sleep with a small portable monitor to measure your breathing, complete daily and weekly questionnaires about your congestion, and have visits to assess how you're doing. The study involves about 52 participants total.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States